Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 19, 2025BiomedicinesOpen Access

Induced Pluripotent Stem Cell-Based Cancer Immunotherapy: Strategies and Perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

XXXiaodong XunJHJialing HaoQCQian Cheng

Discussion

Loading...

Member takes

Overview

Observational analysis explores potential of iPSCs-derived immunocytes in cancer treatment, highlighting personalized therapies and safety concerns.

Key Points

  • Induced pluripotent stem cells (iPSCs) enhance cancer immunotherapy by enabling personalized treatment strategies.
  • Ongoing clinical trials are assessing the effectiveness of iPSCs-derived immunocytes against challenging tumor environments.
  • T cells, dendritic cells, and NK cells derived from iPSCs show promise, but safety issues like cytokine release syndrome need attention.
  • Challenges in targeting efficiency and optimizing immunocyte biological activity remain critical for effective cancer therapies.

Cite This Study

Xun et al. (2025) studied this question.

synapsesocial.com/papers/68af33d5cf1dd9ea359e895bhttps://doi.org/10.3390/biomedicines13082012
View Full Paper
Ask AI
Bookmark
Share